NEWS

Exogenus Therapeutics presents at ISEV Annual Meeting 2021

Exogenus Therapeutics presents at ISEV Annual Meeting 2021

Patricia Freire, one of Exogenus’ scientists, presents some of our recent advances at the ISEV Annual Meeting, happening on May 18th to 21st, virtually. The talk, entitled “Umbilical cord blood-derived small extracellular vesicles: immune-modulating properties and...

read more
Our recent publication featured in Exosome RNA

Our recent publication featured in Exosome RNA

Exosome RNA, an online publication featuring the hottest trends in global exosome research, recently highlighted Exogenus Therapeutics’ contribution to the field, by mentioning our recent publication in Stem Cells Translational Medicine. Exogenus Therapeutics...

read more
Exogenus Therapeutics featured in Labiotech’s article

Exogenus Therapeutics featured in Labiotech’s article

Labiotech.eu, a biotechnology-centered online issue, published an article about exosomes, featuring Exogenus Therapeutics as one of the leading exosome biotechnology companies in Europe. The piece delves into the most recent advances in exosome-based therapeutics and...

read more
New Publication Out: Optimized Method for EV Production

New Publication Out: Optimized Method for EV Production

A paper entitled “Development of an optimized and scalable method for isolation of umbilical cord blood‐derived small extracellular vesicles for future clinical use” was just published in STEM CELLS Translational Medicine. The publication details the protocol...

read more
Exogenus Therapeutics wins Prémio Empreendedor XXI 2018

Exogenus Therapeutics wins Prémio Empreendedor XXI 2018

Exogenus Therapeutics is the winner of the 2nd edition of Prémio Empreendedor XXI, Portugal - North and Central Regions. This prize is organized by BPI and DayOne, a division of CaixaBank specialized in technological companies, in partnership with Agência Nacional de...

read more
Graça Raposo joins Exogenus Therapeutics Advisory Board

Graça Raposo joins Exogenus Therapeutics Advisory Board

We are glad to announce that Graça Raposo, one of the first scientists worldwide who recognized the biological role of Extracellular Vesicles (EVs) in human biology, has joined our Advisory Board. Commonly referred within experts as “the mother of exosomes”, Graça...

read more
Exogenus presents poster at ISEV 2018 Annual meeting

Exogenus presents poster at ISEV 2018 Annual meeting

Exogenus is presenting a poster at ISEV 2018 Annual meeting taking place in Barcelona between 2-6 May. With over 1,000 attendees, ISEV2018 gathers experts and researchers on extracellular vesicle research, covering the latest progresses in exosomes,...

read more
Exogenus present at 1st Meeting on Vesicular Biology

Exogenus present at 1st Meeting on Vesicular Biology

Silvia Rodrigues, PhD student at Exogenus Therapeutics, presented a poster with results on research and development work done on the automatization of cord blood processing for production of an exosome-based medicinal product and its relevance for the scaling up...

read more
Exogenus recognized at BioEurope 2017

Exogenus recognized at BioEurope 2017

Exogenus was recognized at BioEurope 2017, one of the biggest biotech industry events! Listen to Joana Simões Correia on Exogenus Therapeutics: https://www.youtube.com/watch?v=6pyTMGNhPJc Event organizers, EBD Group and Johnson & Johnson Innovation, recognized how...

read more
Exogenus distinguished at Merck Venture Lounge

Exogenus distinguished at Merck Venture Lounge

Exogenus was distinguished as one of the most innovative Life Sciences & Medtech projects in Europe at Merck Venture Lounge, 2017! The Venture Lounge is an initiative of EASME through SME Instrument Phase 3...

read more
Exo-T finalists of the Everis Foundation Award 2016

Exo-T finalists of the Everis Foundation Award 2016

Exo-T are proud to have been chosen as one of the 6 finalists of the Everis Foundation Award 2016.  Selected among 600 projects of the areas of Industry, Biotechnology & Health and Digital, Exo-T is the only Portuguese representative left in the run-up to the...

read more
Exogenus Therapeutics receives 800k euro investment

Exogenus Therapeutics receives 800k euro investment

The startup Exogenous Therapeutics, which was created with the support COHiTEC 2014, has raised a second round of funding worth 800 thousand euros, led by Caixa Capital. The funding will enable the company to advance the development of its innovative treatment for...

read more
Caixa Capital investe 800 mil euros na Exogenus Therapeutics

Caixa Capital investe 800 mil euros na Exogenus Therapeutics

A startup que quer revolucionar a forma como se tratam feridas crónicas, provocadas por doenças como a diabetes, recebeu 800 mil euros numa ronda de investimento liderada pela Caixa Capital. A Exogenus Therapeutics recebeu 800 mil euros numa ronda de investimento...

read more
Exogenus Therapeutics vence prémio Jovem Empreendedor

Exogenus Therapeutics vence prémio Jovem Empreendedor

Startup de Coimbra que quer revolucionar a forma como se tratam feridas crónicas provocadas por doenças como a diabetes foi a vencedora do galardão mais antigo do país na área do empreendedorismo. A startup biotecnológica Exogenus Therapeutics quer...

read more
Empresa recém-criada vence Prémio do Jovem Empreendedor

Empresa recém-criada vence Prémio do Jovem Empreendedor

Uma empresa recém-criada, uma startup, acaba de ganhar o Prémio do Jovem Empreendedor. Empresa criou uma terapia inovadora, um gel para curar lesões de pele. Vai assim receber 30 mil euros para desenvolver esta terapia para curar lesões da pele de doentes com feridas...

read more